| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 784 |
| 1 | DEXAMETHASONE 1.5 MG | 784 |
| 2 | PACLITAXEL | 696 |
| 3 | OXALIPLATIN | 599 |
| 4 | CYCLOPHOSPHAMIDE | 594 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 594 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 594 |
| 7 | PACLITAXEL (AIBUMIN-BOUND) | 544 |
| 8 | BEVACIZUMAB | 496 |
| 9 | PREDNISONE | 450 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELARABINE | 56 | 0.0575 |
| 1 | BRENTUXIMAB VEDOTIN | 145 | 0.0139 |
| 2 | PEGFILGRASTIM | 110 | 0.0092 |
| 3 | LEVOLEUCOVORIN INJECTION | 25 | 0.0081 |
| 4 | OXALIPLATIN | 599 | 0.0079 |
| 5 | PANITUMUMAB | 127 | 0.0079 |
| 6 | BLEOMYCIN SULFATE | 73 | 0.0070 |
| 7 | PACLITAXEL | 696 | 0.0069 |
| 8 | LEVOLEUCOVORIN | 25 | 0.0065 |
| 9 | APREPITANT | 47 | 0.0062 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1389 |
| 1 | Platinum-based Drug [EPC] | 1201 |
| 2 | Microtubule Inhibitor [EPC] | 947 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 841 |
| 4 | Alkylating Drug [EPC] | 689 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 511 |
| 6 | Proteasome Inhibitor [EPC] | 457 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 453 |
| 8 | Thalidomide Analog [EPC] | 384 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 382 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 131 | 0.0224 |
| 1 | CD30-directed Immunoconjugate [EPC] | 145 | 0.0139 |
| 2 | Interleukin-5 Antagonist [EPC] | 8 | 0.0116 |
| 3 | Actinomycin [EPC] | 19 | 0.0086 |
| 4 | Aldehyde Dehydrogenase Inhibitor [EPC] | 8 | 0.0070 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 54 | 0.0062 |
| 6 | Microtubule Inhibitor [EPC] | 947 | 0.0057 |
| 7 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 29 | 0.0046 |
| 8 | Platinum-based Drug [EPC] | 1201 | 0.0044 |
| 9 | Enzyme Stabilizer [EPC] | 5 | 0.0043 |